Order Article Reprints

Samaha R, El Sayed R, Alameddine R, Florescu M, Tehfe M, Routy B, Elkrief A, Belkaid W, Desilets A, Weng X, et al. Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study). Current Oncology. 2025; 32(2):57. https://doi.org/10.3390/curroncol32020057

Samaha, Ramy, Rola El Sayed, Raafat Alameddine, Marie Florescu, Mustapha Tehfe, Bertrand Routy, Arielle Elkrief, Wiam Belkaid, Antoine Desilets, Xiaoduan Weng, and et al. 2025. "Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study)" Current Oncology 32, no. 2: 57. https://doi.org/10.3390/curroncol32020057

Samaha, R., El Sayed, R., Alameddine, R., Florescu, M., Tehfe, M., Routy, B., Elkrief, A., Belkaid, W., Desilets, A., Weng, X., Nassabein, R., Blanc-Durand, F., Kenth, G., Kasymjanova, G., Agulnik, J., & Blais, N. (2025). Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study). Current Oncology, 32(2), 57. https://doi.org/10.3390/curroncol32020057